Common use of EXPERTS Clause in Contracts

EXPERTS. The financial statements of Luminar Technologies, Inc. incorporated by reference in this prospectus, and the effectiveness of Luminar Technologies, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm, given their authority as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stock. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public free of charge at the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxx. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus is a part of the registration statement and does not contain all the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through the SEC’s website, as provided above.

EXPERTS. The financial statements of Luminar Technologies, Inc. as of and for the years ended December 31, 2020 and 2019 incorporated by reference in this prospectus, and the effectiveness of prospectus by reference to Luminar Technologies, Inc.’s internal control over financial reporting Annual Report on Form 10–K for the year ended December 31, 2020 have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reportsreport. Such financial statements are incorporated by reference in reliance upon the reports report of such firm, firm given their authority as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated This prospectus is part of a registration statement we filed with the firm own and/or have an indirect interest in shares of Class A common stockSEC. This prospectus, which represent less than 1% constitutes part of the registration statement, does not contain all of the information set forth in the registration statement and the exhibits and schedules thereto. For further information with respect to the Company and its securities, reference is made to the registration statement and the exhibits and any schedules filed therewith. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. You can read our Class A common stockSEC filings, including the registration statement, over the Internet at the SEC’s website at xxx.xxx.xxx. We are subject to the information reporting requirements of the Exchange Act and we are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings These reports, proxy statements, and other information are available to the public free of charge for inspection and copying at the SEC’s website at xxx.xxx.xxxreferred to above. Copies of certain information filed by us with the SEC are We also available on the “Investors” page of our maintain a website at xxx.xxxxxxxxxxx.xxx, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible through our website is not incorporated by reference into a part of this prospectus, and you should not consider any information on, or that can be accessed from, the inclusion of our website as part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus is a part of the registration statement and does not contain all the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements address in this prospectus concerning any document we filed as is an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by inactive textual reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through the SEC’s website, as provided aboveonly.

EXPERTS. The financial statements of Luminar TechnologiesRose, Inc. incorporated by reference in this prospectus, and the effectiveness of Luminar Technologies, Inc.’s internal control over financial reporting have been audited by Deloitte Xxxxxx & Touche Xxxxxx LLP, an independent registered public accounting firm, as stated has audited our financial statements included in their reportsour annual report on Form 10-K for the year ended December 31, 2020, which is incorporated by reference into this prospectus supplement and elsewhere in the registration statement of which this prospectus supplement is a part. Such Our financial statements are incorporated by reference in reliance upon the reports of such firmon Rose, Xxxxxx & Xxxxxx LLP’s report, given on their authority as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP We are a reporting company and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stock. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public free of charge at the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxx. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating under the Securities Act with respect to the securities covered by being offered under this prospectusprospectus supplement. This prospectus is supplement does not contain all of the information set forth in the accompanying prospectus, the registration statement and the exhibits to the registration statement. For further information with respect to us and the securities being offered under this prospectus supplement, we refer you to the accompanying prospectus, the registration statement and the exhibits and schedules filed as a part of the registration statement statement. You may read and does not contain all the information in copy the registration statement. Other documents establishing the terms of the offered securities are or may be filed , as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information well as our reports, proxy statements and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through other information, at the SEC’s websitePublic Reference Room at 000 X Xxxxxx, as provided aboveX.X., Xxxxxxxxxx, X.X. 00000. Please call the SEC at 0-000-XXX-0000 for more information about the operation of the Public Reference Room. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including Capricor Therapeutics, Inc. The SEC’s Internet site can be found at xxxx://xxx.xxx.xxx.

EXPERTS. The consolidated financial statements of Luminar TechnologiesIGC Pharma, Inc. included in our annual report on Form 10-K for the fiscal year ended March 31, 2023, and March 31, 2022, have been audited by Xxxxxxx Xxxxxxxx & Associates, independent registered public accountants, as set forth in their reports thereon, included therein, and incorporated herein by reference in this prospectus, prospectus supplement and elsewhere in the effectiveness of Luminar Technologies, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reportsregistration statement. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the reports authority of such firm, given their authority said firm as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stock. We file annual, quarterly and current reports, proxy statements statements, and other information documents with the SEC. You may read and copy any document we file at the SEC’s public reference room at 000 X Xxxxxx, X.X., Xxxx 0000, Xxxxxxxxxx, X.X. 00000. You should call 0-000-XXX-0000 for more information on the operation of the public reference room. Our SEC filings are also available to the public free of charge at you on the SEC's Internet site at xxxx://xxx.xxx.xxx. The SEC’s website at xxx.xxx.xxx. Copies of certain Internet site contains reports, proxy and information filed by us statements, and other information regarding issuers that file electronically with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxxSEC. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as This prospectus supplement constitutes a part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to that we have filed with the securities covered by this prospectusSEC under the Securities Act. This prospectus is a part supplement does not contain all of the information set forth in the registration statement, certain parts of which are omitted in accordance with the rules and regulations of the SEC. For further information about us and our securities, we refer you to the registration statement and does not contain all the information in the accompanying exhibits and schedules. The registration statement. Other documents establishing the terms of the offered securities are or statement may be filed as exhibits to inspected at the registration statement or documents incorporated Public Reference Room maintained by reference in the registration statement. You should review SEC at the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offeringaddress set forth above. Statements contained in this prospectus concerning supplement regarding the contents of any contract or any other document we filed as an exhibit are not necessarily complete. In each instance, reference is made to the copy of such contract or document filed as an exhibit to the registration statement, and each statement or is qualified in all respects by that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through the SEC’s website, as provided abovereference.

EXPERTS. The consolidated financial statements of Luminar TechnologiesForte Biosciences, Inc. as of and for the years ended December 31, 2020 and 2019 incorporated by reference in this prospectusregistration statement, and the effectiveness of Luminar Technologieswhich this prospectus forms a part, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche LLPXxxxx Xxxxxxx XxXxxx P.C., an independent registered public accounting firm, as stated in set forthin their reports. Such financial statements report, and are incorporated by reference included in reliance upon such report given on the reports authority of such firm, given their authority firm as experts in auditing and accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stockgiving said report. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public free of charge over the Internet at the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxxxxx.xxxxxxxxxx.xxx. Information contained accessible on or through our website is not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as a part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus and any prospectus supplement is a part of the a registration statement that we filed with the SEC and does do not contain all of the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities that we are offering. Forms of any indenture or other documents establishing the terms of the offered securities are filed as exhibits to the registration statement of which this prospectus forms a part or under cover of a Current Report on Form 8-K and incorporated in this prospectus by reference. Statements in this prospectus concerning or any document we filed as an exhibit to the registration prospectus supplement about these documents are summaries and each statement or that we otherwise filed with the SEC are not intended to be comprehensive and are is qualified in all respects by reference to these filingsthe document to which it refers. You should review read the actual documents for a more complete document to evaluate these statements. You may review a copy description of the registration statement through the SEC’s website, as provided aboverelevant matters.

EXPERTS. The consolidated financial statements of Luminar TechnologiesVyant Bio Inc. and subsidiaries as of and for the years ended December 31, Inc. 2021 and 2020, incorporated by reference in this prospectusprospectus supplement, and the effectiveness of Luminar Technologies, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reportsreport. Such financial statements are incorporated by reference in reliance upon the reports report of such firm, firm given their authority as experts in accounting auditing and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stockaccounting. We file annualannual reports, quarterly and reports, current reports, proxy statements and other information with the SEC. Our SEC filings are and will become available to the public free of charge over the Internet at the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are You can also available find our public filings on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxxxxx.xxxxxxxxxxxx.xxx. Information Our website and the information contained on our website is therein or connected thereto are not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as part of this prospectus supplement or any the accompanying prospectus supplementprospectus. We have filed with the SEC a registration statement on Form S-3 relating under the Securities Act with respect to the securities covered shares of common stock being offered by this prospectusprospectus supplement. This prospectus is supplement and the accompanying prospectus are a part of that registration statement but do not contain all of the information set forth in the registration statement or the exhibits to the registration statement. For further information with respect to us and the shares we are offering pursuant to this prospectus supplement, you should refer to the registration statement and does not contain all the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offeringits exhibits. Statements contained in this prospectus concerning supplement as to the contents of any contract, agreement or other document we referred to are not necessarily complete, and you should refer to the copy of that contract or other documents filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statementsstatement. You may review read or obtain a copy of the registration statement through at the SEC’s website, as provided website referred to above.

EXPERTS. The consolidated financial statements as of Luminar TechnologiesDecember 31, Inc. 2018 and 2017, and for each of the three years in the period ended December 31, 2018, and management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2018, incorporated by reference in this prospectus, and the effectiveness of Luminar Technologies, Inc.’s internal control over financial reporting prospectus supplement have been audited by Deloitte & Touche so incorporated in reliance on the reports of BDO USA, LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated herein by reference in reliance upon the reports of such firmreference, given their on the authority of said firm as experts in accounting auditing and auditingaccounting. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP This prospectus supplement and certain funds affiliated the accompanying prospectus are part of a registration statement on Form S-3 that we filed with the firm own and/or SEC under the Securities Act. This prospectus supplement and the accompanying prospectus do not contain all of the information included in the registration statement. We have an indirect interest omitted certain parts of the registration statement in shares accordance with the rules and regulations of Class A common stockthe SEC. For further information, which represent less than 1% we refer you to the registration statement, including its exhibits and schedules. Statements contained in this prospectus supplement and the accompanying prospectus about the provisions or contents of our Class A common stockany contract, agreement or any other document referred to are not necessarily complete. Please refer to the actual exhibit for a more complete description of the matters involved. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings filings, including the registration statement and exhibits, are available to the public free of charge at the SEC’s website at xxx.xxx.xxxxxxx://xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on the “Investors” page of our website We maintain an Internet site at xxx.xxxxxxxxxxx.xxxxxx.xxxxxxxxxxxx.xxx. Information contained on our website is We have not incorporated by reference into this prospectusprospectus supplement or the accompanying prospectus the information on our website, and you should not consider any of the information on, posted on or that can be accessed from, hyper-linked to our website as to be a part of this prospectus supplement or any the accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus is a part of the registration statement and does not contain all the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through the SEC’s website, as provided above.

EXPERTS. The consolidated financial statements of Luminar TechnologiesZynerba Pharmaceuticals, Inc. and subsidiary as of December 31, 2020 and 2019 and for each of the years in the three-year period ended December 31, 2020, have been incorporated by reference herein in this prospectus, and reliance upon the effectiveness report of Luminar Technologies, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche KPMG LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance herein, and upon the reports authority of such firm, given their authority said firm as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated This prospectus supplement is part of a registration statement we filed with the firm own and/or have an indirect interest SEC. This prospectus supplement does not contain all of the information set forth in shares the registration statement and the exhibits to the registration statement. For further information with respect to us and the securities we are offering under this prospectus supplement, we refer you to the registration statement and the exhibits and schedules filed as a part of Class A common stock, which represent less than 1% of our Class A common stockthe registration statement. You should rely only on the information contained in this prospectus supplement or incorporated by reference. We have not authorized anyone else to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus supplement is accurate as of any date other than the date on the front page of this prospectus supplement, regardless of the time of delivery of this prospectus supplement or any sale of the securities offered by this prospectus supplement. We are currently subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and in accordance therewith file annual, quarterly and current periodic reports, proxy statements and other information with the SEC. Our SEC filings are available to the public free of charge at you on the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on xxxx://xxx.xxx.xxx and in the “InvestorsInvestor Relations” page section of our website at xxx.xxxxxxxxxxx.xxxxxxx://xxx.xxxxxxx.xxx. Information Our website and the information contained on our website is that site, or connected to that site, are not incorporated by reference into this prospectus, and you should are not consider any information on, or that can be accessed from, our website as a part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus is a part of the registration statement and does not contain all the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through the SEC’s website, as provided above.

EXPERTS. The financial statements Our consolidated balance sheets as of Luminar TechnologiesDecember 31, Inc. incorporated by reference in this prospectus2019 and 2018, and the effectiveness related consolidated statements of Luminar Technologiesoperations, Inc.’s internal control over financial reporting stockholders’ equity and cash flows for each of those two years have been audited by Deloitte & Touche Xxxxxxxx LLP, an independent registered public accounting firm, as stated set forth in their reports. Such financial statements are its report incorporated by reference and are included in reliance upon such report given on the reports authority of such firm, given their authority firm as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stock. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our The SEC filings are available to the public free of charge at maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC’s . The address of that website at xxx.xxx.xxxis xxxx://xxx.xxx.xxx. Copies of certain Our website address is xxxxx://xxx.xxxxxxxxxxxxx.xxx. The information filed by us with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxx. Information contained on our website website, however, is not incorporated by reference into this prospectusnot, and you should not consider any information onbe deemed to be, or that can be accessed from, our website as a part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus is a and any prospectus supplement are part of the a registration statement that we filed with the SEC and does do not contain all of the information in the registration statement. Other The full registration statement may be obtained from the SEC or us, as provided below. Forms of the documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning or any document we filed as an exhibit to the registration prospectus supplement about these documents are summaries and each statement or that we otherwise filed with the SEC are not intended to be comprehensive and are is qualified in all respects by reference to these filingsthe document to which it refers. You should review refer to the actual documents for a more complete document to evaluate these statementsdescription of the relevant matters. You may review inspect a copy of the registration statement at the SEC’s Public Reference Room in Washington, D.C. or through the SEC’s website, as provided above.

EXPERTS. The financial statements of Luminar Technologies, Inc. incorporated in this prospectus supplement by reference in this prospectusfrom the Company’s Annual Report on Form 10-K, and the effectiveness of Luminar Technologies, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reportsreport, which is incorporated herein by reference. Such financial statements are have been so incorporated by reference in reliance upon the reports report of such firm, firm given upon their authority as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP We are a reporting company and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stock. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public free of charge at the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxx. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our website as part of this prospectus or any accompanying prospectus supplement. We have filed with the SEC a registration statement on Form S-3 relating under the Securities Act with respect to the securities covered by being offered under this prospectus supplement and the accompanying prospectus. This prospectus is supplement and the accompanying prospectus do not contain all of the information set forth in the registration statement and the exhibits to the registration statement. For further information with respect to us and the securities being offered under this prospectus supplement and the accompanying prospectus, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement statement. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including Fulgent. The SEC's Internet site can be found at xxxx://xxx.xxx.xxx. We maintain a website at xxx.xxxxxxxxxxxxxxx.xxx. Information contained in or accessible through our website does not contain all the information in the registration statement. Other documents establishing the terms constitute a part of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to supplement or the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You may review a copy of the registration statement through the SEC’s website, as provided aboveaccompanying prospectus.

EXPERTS. The financial statements consolidated balance sheets of Luminar TechnologiesEkso Bionics Holdings, Inc. incorporated by reference in this prospectusas of December 31, 2022 and 2021, and the effectiveness related consolidated statements of Luminar Technologiesoperations and comprehensive loss, Inc.’s internal control over financial reporting stockholders’ equity and cash flows for each of the years in the two-year period ended December 31, 2022, have been audited by Deloitte & Touche LLPWithumSmith+Brown, an PC, independent registered public accounting firm, as stated in their reportsreport which is incorporated herein by reference. Such financial statements are have been incorporated herein by reference in reliance upon on the reports report of such firm, firm given upon their authority as experts in accounting and auditing. Certain attorneys with Xxxxxx, Xxxxxxxxxx & Xxxxxxxxx LLP and certain funds affiliated with the firm own and/or have an indirect interest in shares of Class A common stock, which represent less than 1% of our Class A common stock. We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public free of charge over the Internet at the SEC’s website at xxx.xxx.xxx. Copies of certain information filed by us with the SEC are also available on the “Investors” page of our website at xxx.xxxxxxxxxxx.xxxxxxxx.xxxxxxxxxxx.xxx. Information contained accessible on or through our website is not incorporated by reference into this prospectus, prospectus supplement and you should shall not consider any information on, or that can it to be accessed from, our website as a part of this prospectus or any accompanying prospectus supplement. We have This prospectus supplement and any prospectus supplement is part of a registration statement that we filed with the SEC a registration statement on Form S-3 relating to the securities covered by this prospectus. This prospectus is a part of the registration statement and does do not contain all of the information in the registration statement. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities that we are offering. Statements in this prospectus concerning supplement or any document we filed as an exhibit to the registration prospectus supplement about these documents are summaries and each statement or that we otherwise filed with the SEC are not intended to be comprehensive and are is qualified in all respects by reference to these filingsthe document to which it refers. You should review read the actual documents for a more complete document to evaluate these statements. You may review a copy description of the registration statement through the SEC’s website, as provided aboverelevant matters.